TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11226784

Group type: EXPERIMENTAL
Intervention: Healon5 (sodium hyaluronate 2.3%)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Viscoat (sodium hyaluronate 3.0%-chondroitin sulfate 4.0%)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: OcuCoat (hydroxypropyl methylcellulose 2.0%)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Celoftal (hydroxypropyl methylcellulose 2.0%)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Healon GV (sodium hyaluronate 1.4%)
Number of subjects: 81
Study: 9522023

Group type: EXPERIMENTAL
Intervention: Chloral hydrate (therapeutic doses)
Number of subjects: 18
Study: 7856290

Group type: EXPERIMENTAL
Intervention: CFA/II in biodegradable polymer microspheres (BPM), 1 mg administered via intestinal tube on days 0, 7, 14, and 28.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (unvaccinated volunteers).
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CFA/II in biodegradable polymer microspheres (BPM).
Number of subjects: 10
Study: 2796243

Group type: EXPERIMENTAL
Intervention: Aminophyllin treatment (oral, therapeutic range 4-10 micrograms/ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No aminophyllin treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study: 338270

Group type: EXPERIMENTAL
Intervention: Haloperidol (n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thiothixene (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Haloperidol and Thiothixene (combined)
Number of subjects: 30
Study: 30988133

Group type: EXPERIMENTAL
Intervention: Candesartan (AT1R receptor antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin II (AngII)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C21 (AT2R-selective agonist)
Number of subjects: 0
Study: 26961091

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25549193

Group type: EXPERIMENTAL
Intervention: Contralateral C7 neurotization surgery
Number of subjects: 6

Group type: COMPARATOR
Intervention: Rehabilitation only (Control)
Number of subjects: 6
Study: 23830306

Group type: EXPERIMENTAL
Intervention: Avoidance diet for egg protein intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral tolerance induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omalizumab (anti-IgE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triple viral vaccine (MMR)
Number of subjects: 0
Study: 22164960

Group type: COMPARATOR
Intervention: Fumaric acid supplementation (0 g/d, 100 g/d, 200 g/d, 300 g/d) with maize silage
Number of subjects: 62

Group type: COMPARATOR
Intervention: Fumaric acid supplementation (0 g/d, 100 g/d, 200 g/d, 300 g/d) with grass silage
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Fumaric acid supplementation (300 g/d)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (0 g/d fumaric acid)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Fumaric acid supplementation (0 g/d, 300 g/d)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Silage type (maize vs grass)
Number of subjects: 62
Study: 19438778

Group type: EXPERIMENTAL
Intervention: Carpentier‐Edwards Perimount
Number of subjects: 86

Group type: COMPARATOR
Intervention: SJM Epic
Number of subjects: 86
Study: 16776791

Group type: EXPERIMENTAL
Intervention: Occupational therapy and physical therapy sessions involving home modifications, problem solving, and training in energy conservation, safe performance, balance, muscle strength, and fall recovery techniques.
Number of subjects: 319

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Occupational therapy and physical therapy intervention
Number of subjects: 319
Study: 14702451

Group type: EXPERIMENTAL
Intervention: Behavioral skills training program
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Eddie Eagle GunSafe Program
Number of subjects: 31

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 31
Study: 11562581

Group type: EXPERIMENTAL
Intervention: Hypothermic pulsatile (n=9, 2.5 L)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Normothermic pulsatile (n=8, 2.5 L/min/m2)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Normothermic nonpulsatile (n=12, 2.5 L)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Normothermic nonpulsatile (n=12, 2.8 L)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Hypothermic nonpulsatile (n=11, 2.5 L)
Number of subjects: 52
Study: 9158469

Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 198

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 198
Study: 8201064

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard procedures to maintain pharmacotherapy blinds
Number of subjects: 0
Study: 3047304

Group type: EXPERIMENTAL
Intervention: Sulprostone 500 mcg 3 times at 4-hour intervals (regimen 1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sulprostone 500 mcg every 6 hours for up to 6 injections (regimen 2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intrauterine fetal death cases treated with regimen 1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Failures in regimen 1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 12
Study: 28952176

Group type: EXPERIMENTAL
Intervention: 2% Cryosim‐1 cream applied twice daily for seven days
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo-vehicle cream applied twice daily for seven days
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2% Cryosim‐1 cream
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo-vehicle cream
Number of subjects: 9
Study: 28336747

Group type: EXPERIMENTAL
Intervention: Dietary pulse intake
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Available carbohydrate
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Glycaemic load
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Starch
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Total fat intake
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Saturated fat intake
Number of subjects: 325
Study: 25676011

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 40
Study: 23288407

Group type: EXPERIMENTAL
Intervention: Multisensory stimulation (Auditory, Tactile, Visual and Vestibular stimulus) for 12 min per session, 5 sessions per week
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Multisensory stimulation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine NICU care
Number of subjects: 50
Study: 21905251

Group type: EXPERIMENTAL
Intervention: Knee extensor strength and standing balance
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Standing balance in the anteroposterior plane
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Standing balance-physical function associations
Number of subjects: 104
Study: 18369591

Group type: EXPERIMENTAL
Intervention: ACCM/PALS with ScvO(2) goal-directed therapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: ACCM/PALS without ScvO(2) goal-directed therapy
Number of subjects: 102
Study: 16818864

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 99

Group type: COMPARATOR
Intervention: Cognitive behavior therapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 99
Study: 12614309

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 100 mg/day
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 200 mg/day
Number of subjects: 613

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ) 600 mg/day
Number of subjects: 613

Group type: COMPARATOR
Intervention: Valproate (VPA) 1250 mg/day
Number of subjects: 613
Study: 10940544

Group type: EXPERIMENTAL
Intervention: Self-help group attendance and participation
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Self-help group emphasis in treatment
Number of subjects: 411
Study: 9044341

Group type: EXPERIMENTAL
Intervention: 5-h haemodialysis sessions
Number of subjects: 38

Group type: COMPARATOR
Intervention: 4-h haemodialysis sessions
Number of subjects: 38
Study: 7817684

Group type: EXPERIMENTAL
Intervention: KH 1060 ointment 0.2 microgram/g
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: KH 1060 ointment 1 microgram/g
Number of subjects: 70

Group type: COMPARATOR
Intervention: KH 1060 ointment 0.04 microgram/g
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 70
Study: 3294405

Group type: EXPERIMENTAL
Intervention: Ticarcillin disodium/clavulanate potassium
Number of subjects: 47

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 47
Study: 31837264

Group type: EXPERIMENTAL
Intervention: Sotagliflozin 400 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 29098426

Group type: EXPERIMENTAL
Intervention: Multifunctional diet (MFD) for 8 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control diet lacking functional components for 8 weeks
Number of subjects: 47
Study: 28132008

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 26383718

Group type: EXPERIMENTAL
Intervention: Self-expanding transcatheter aortic valve replacement (TAVR)
Number of subjects: 489
Study: 23333772

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 20816031

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics (4 types)
Number of subjects: 1197
Study: 18639298

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg)
Number of subjects: 3047

Group type: EXPERIMENTAL
Intervention: Combination of doxazosin (4 to 8 mg) and finasteride (5 mg)
Number of subjects: 3047

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3047
Study: 17054068

Group type: EXPERIMENTAL
Intervention: Recombinant vaccine (rHAO) 45 microg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Recombinant vaccine (rHAO) 135 microg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Commercial trivalent influenza vaccine (TIV)
Number of subjects: 27
Study: 14749151

Group type: EXPERIMENTAL
Intervention: Ramosetron 3 microg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ramosetron 6 microg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ramosetron 12 microg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 10671836

Group type: COMPARATOR
Intervention: No cricoid pressure
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cricoid pressure applied with a force of 30 N
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cricoid pressure applied in an upward and backward direction with a force of 30 N
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cricoid pressure at 44 N
Number of subjects: 52
Study: 7675601

Group type: EXPERIMENTAL
Intervention: Dynavision tasks of graded difficulty
Number of subjects: 0
Study: 2239779

Group type: EXPERIMENTAL
Intervention: Uncooked cornstarch (UCS)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: UCS:Dex (3:1 mixture)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dextrose (Dex)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Continuous intragastric glucose infusion (COG)
Number of subjects: 7
Study: 7360547

Group type: EXPERIMENTAL
Intervention: Feedback concerning an audiovisually taped interview and participation in a didactic session on interviewing skills (Group 1)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Feedback sessions only (Group 2)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Neither feedback nor didactic sessions (Group 3)
Number of subjects: 62
Study: 30833136

Group type: EXPERIMENTAL
Intervention: Dialogical Sequence Analysis (DSA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual Psychiatric Assessments (AAU)
Number of subjects: 10
Study: 28483270

Group type: EXPERIMENTAL
Intervention: Counseling (5 consultations by an Advanced Practice Nurse over 6 months)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Written information (predefined set of leaflets)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 49

Group type: COMPARATOR
Intervention: Written information
Number of subjects: 49
Study: 25566971

Group type: EXPERIMENTAL
Intervention: Emotional strategies employed by staff when notifying patients about treatment allocation.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Need for practical, emotional, and specialist psychological support for trial staff.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Emotional management of patients and colleagues by trial staff.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Impact of patient withdrawal or non-randomization on staff emotions.
Number of subjects: 18
Study: 23416808

Group type: EXPERIMENTAL
Intervention: Bilateral superficial cervical plexus block with 0.25% bupivacaine 15ml on each side
Number of subjects: 60

Group type: COMPARATOR
Intervention: No regional block administered (Control)
Number of subjects: 60
Study: 21111539

Group type: EXPERIMENTAL
Intervention: Enjoyment of smoking
Number of subjects: 2257

Group type: EXPERIMENTAL
Intervention: Strength of urges to smoke
Number of subjects: 2257
Study: 19664676

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 40
Study: 17280633

Group type: EXPERIMENTAL
Intervention: Glucosamine sulphate (1500 mg per day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 15127380

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pacing
Number of subjects: 0

Group type: COMPARATOR
Intervention: No atrial fibrillation prophylaxis
Number of subjects: 0
Study: 11240976

Group type: COMPARATOR
Intervention: Nifedipine (20 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Mibefradil (100 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Amlodipine (10 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9609505

Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT) intervention
Number of subjects: 46
Study: 8923781

Group type: EXPERIMENTAL
Intervention: Iron supplementation (66 mg ferrous iron daily)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 2479227

Group type: EXPERIMENTAL
Intervention: Melperone (300 mg daily)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Thiothixene (30 mg daily)
Number of subjects: 81
Study: 1098177

Group type: EXPERIMENTAL
Intervention: Bismuth-protein complex (Bicitropeptide, BCP-Compound)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31059588

Group type: EXPERIMENTAL
Intervention: Abiraterone plus prednisone
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 1088
Study: 28085541

Group type: EXPERIMENTAL
Intervention: Standardized patient (SP) actor‐based simulation in advance care planning (ACP) facilitator training course
Number of subjects: 67
Study: 25527736

Group type: EXPERIMENTAL
Intervention: Cocoa extract (1.4 g/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control meals (placebo)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cocoa extract (1.4 g/day) and Control meals
Number of subjects: 50
Study: 23497835

Group type: EXPERIMENTAL
Intervention: Beliefs about behaviour
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Illness perceptions
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Past behaviour, trial group allocation, and clinical and demographic factors
Number of subjects: 453
Study: 21690465

Group type: EXPERIMENTAL
Intervention: Regular completion of European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire‐Core 30 and Hospital Anxiety and Depression Scale with feedback to oncologists
Number of subjects: 198

Group type: COMPARATOR
Intervention: Completion of same questionnaires without feedback
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 198
Study: 19448051

Group type: EXPERIMENTAL
Intervention: Integrative reminiscence
Number of subjects: 56

Group type: COMPARATOR
Intervention: Attention control (health education)
Number of subjects: 56

Group type: COMPARATOR
Intervention: True control
Number of subjects: 56
Study: 16684940

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive-behavior treatment (CBT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Nonspecific intervention to improve adherence to medical recommendations
Number of subjects: 65
Study: 15358979

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Clozapine
Number of subjects: 15
Study: 10659875

Group type: EXPERIMENTAL
Intervention: Zidovudine, 160 mg/m2 3 times per day plus lamivudine, 4 mg/kg 2 times per day
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Ritonavir, 350 mg/m2 2 times per day plus zidovudine and lamivudine
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Ritonavir, 350 mg/m2 2 times per day plus stavudine, 4 mg/kg 2 times per day
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Ritonavir plus 2 nucleosides
Number of subjects: 297

Group type: COMPARATOR
Intervention: Ritonavir plus 1 nucleoside
Number of subjects: 297
Study: 9231929

Group type: EXPERIMENTAL
Intervention: Nicotinamide alone (80 mg kg(‐1) daily) with 52.5 Gy in 20 fractions over 4 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carbogen alone with 50 Gy in 20 fractions over 4 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carbogen and nicotinamide with 50-52.5 Gy in 20 fractions over 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 30
Study: 8149688

Group type: EXPERIMENTAL
Intervention: Normal sodium intake
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High sodium intake (5th day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low sodium intake (5th day)
Number of subjects: 42
Study: 4063284

Group type: EXPERIMENTAL
Intervention: Guar gum (5 or 6 g) with carbohydrate meal (80 ml Hycal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guar gum (5 or 6 g) with protein meal (150 g cooked lean minced beef)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guar gum (5 or 6 g) with fat meal (200 ml double cream)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guar gum (5 g/l solution in water)
Number of subjects: 0
Study: 31353274

Group type: EXPERIMENTAL
Intervention: Credentialing of interventionists based on review of last 25 consecutive cases and self-reported lifetime experience.
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Median self-reported lifetime case experience for those approved.
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Median number of cases submitted for review.
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Number of CAS procedures performed per month (case rate).
Number of subjects: 334
Study: 29933239

Group type: EXPERIMENTAL
Intervention: Early recovery of continuous background activity (within 24 hours)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Early appearance of an epileptiform EEG
Number of subjects: 134
Study: 27163499

Group type: COMPARATOR
Intervention: Ritobegron (20 mg) alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ritobegron (20 mg) with probenecid
Number of subjects: 12
Study: 24085290

Group type: EXPERIMENTAL
Intervention: Natural frequencies (n = 29)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conditional probabilities (n = 34)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Conditional probabilities with a tree diagram (n = 35)
Number of subjects: 102
Study: 22922564

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 3.0 g/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide (IVC) 0.5‐1.0 g/m(2)/month
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1.0 g twice daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral azathioprine (AZA) 2 mg/kg/day
Number of subjects: 24
Study: 19101495

Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% lidocaine
Number of subjects: 40
Study: 17202885

Group type: EXPERIMENTAL
Intervention: Decompressive surgery (undercutting laminectomy, with transpedicular fusion in 10 patients)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 94

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 94
Study: 15252741

Group type: EXPERIMENTAL
Intervention: P wave signal averaged ECG after electrical cardioversion
Number of subjects: 49
Study: 11517139

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 5 microg x kg(‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 10 microg x kg(‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE) 15 microg x kg(‐1)
Number of subjects: 30
Study: 9779768

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Rifampin (600 mg twice daily for four doses)
Number of subjects: 500
Study: 7932137

Group type: EXPERIMENTAL
Intervention: Group A (surgery duration > 40 minutes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group B (surgery duration < 40 minutes)
Number of subjects: 40
Study: 2894658

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 7412801

Group type: COMPARATOR
Intervention: Heparin followed by oral anticoagulants
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thrombolytic agents (urokinase or streptokinase followed by heparin and then by oral anticoagulants)
Number of subjects: 40